Clinical trial
Effects of Subtenon Autologous Platelet-Rich Plasma Injection on Geographic Atrophy Progression, Visual Function, and Quality of Life in Advanced Dry Age-Related Macular Degeneration
NCT07428798 is registered in ClinicalTrials.gov with Marmara University Pendik Training and Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Subtenon Autologous Platelet-Rich Plasma Injection on Geographic Atrophy Progression, Visual Function, and Quality of Life in Advanced Dry Age-Related Macular Degeneration
- Lead sponsor
- Marmara University Pendik Training and Research Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 1, 2024
- Completion date
- October 30, 2024
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dry age related macular degeneration, geographic atrophy